Clinical Evidence And Institutional AdoptionOngoing PTSD clinical trials and publication of controlled military training results could support an expanded regulatory indication and greater adoption within VA and Department of Defense channels if outcomes are favorable.
Revenue PerformancePreliminary full-year revenues matched management guidance and analyst consensus, indicating sustained commercial momentum for the vagus nerve stimulation platform.
Salesforce ExpansionManagement's decision to expand the salesforce is expected to broaden market coverage and support higher device and product sales.